[96a5a0]: / output / allTrials / identified / NCT00322920_identified.json

Download this file

505 lines (505 with data), 21.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
{
"info": {
"nct_id": "NCT00322920",
"official_title": "A Phase I Study of Weekly Topotecan With Cisplatin for the Management of Advanced Stage or Recurrent Carcinoma of the Cervix",
"inclusion_criteria": "* Patients must have persistent, recurrent, or primary Stage IVB carcinoma of the cervix not amenable to curative therapy with either surgery and/or radiation.\n* Patients must have biopsy proven squamous cell, adenosquamous, or adenocarcinoma histology.\n* Patients do not require measurable disease.\n* Patients must have adequate organ function defined by laboratory work.\n* Patients must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.\n* Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy. A minimum of six weeks shall have passed since the last administration of chemoradiotherapy or three weeks for radiation therapy alone.\n* Patients must be free of clinically significant infections.\n* Patients must be age 19 or greater and have signed informed consent.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Patients who are pregnant or lactating.\n* Patients with history of other malignancies (except non-melanoma skin cancer) within the last 5 years are ineligible.\n* Patients with non-squamous, adenosquamous, or adenocarcinoma histology.\n* Patients with bilateral hydronephrosis that cannot be alleviated by ureteral stents or percutaneous drainage.\n* Patients currently receiving any or having received other investigational agents within the last 30 days are ineligible.\n* Patients with known hypersensitivity to topotecan or cisplatin.\n* Patients with craniospinal metastases.\n* Patients with uncontrolled current illness including, but not limited to, ongoing or active infection, unstable angina pectoris, cardiac arrhythmia, serious peripheral neuropathy, or psychiatric illness/social situations that would limit or preclude compliance with study requirements are ineligible.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must have persistent, recurrent, or primary Stage IVB carcinoma of the cervix not amenable to curative therapy with either surgery and/or radiation.",
"criterions": [
{
"exact_snippets": "persistent, recurrent, or primary Stage IVB carcinoma of the cervix",
"criterion": "carcinoma of the cervix",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IVB"
},
{
"requirement_type": "persistence",
"expected_value": true
},
{
"requirement_type": "recurrence",
"expected_value": true
},
{
"requirement_type": "primary",
"expected_value": true
}
]
},
{
"exact_snippets": "not amenable to curative therapy with either surgery and/or radiation",
"criterion": "amenability to curative therapy",
"requirements": [
{
"requirement_type": "amenability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must have biopsy proven squamous cell, adenosquamous, or adenocarcinoma histology.",
"criterions": [
{
"exact_snippets": "biopsy proven squamous cell",
"criterion": "squamous cell histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "biopsy proven ... adenosquamous",
"criterion": "adenosquamous histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "biopsy proven ... adenocarcinoma histology",
"criterion": "adenocarcinoma histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients do not require measurable disease.",
"criterions": [
{
"exact_snippets": "do not require measurable disease",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must have adequate organ function defined by laboratory work.",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy. A minimum of six weeks shall have passed since the last administration of chemoradiotherapy or three weeks for radiation therapy alone.",
"criterions": [
{
"exact_snippets": "Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy.",
"criterion": "recovery from treatment effects",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "A minimum of six weeks shall have passed since the last administration of chemoradiotherapy",
"criterion": "time since last chemoradiotherapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "three weeks for radiation therapy alone",
"criterion": "time since last radiation therapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patients must be free of clinically significant infections.",
"criterions": [
{
"exact_snippets": "free of clinically significant infections",
"criterion": "clinically significant infections",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must be age 19 or greater and have signed informed consent.",
"criterions": [
{
"exact_snippets": "age 19 or greater",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "years"
}
}
]
},
{
"exact_snippets": "signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "healthy volunteers",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who are pregnant or lactating.",
"criterions": [
{
"exact_snippets": "Patients who are pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with history of other malignancies (except non-melanoma skin cancer) within the last 5 years are ineligible.",
"criterions": [
{
"exact_snippets": "history of other malignancies (except non-melanoma skin cancer) within the last 5 years",
"criterion": "history of other malignancies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Patients with non-squamous, adenosquamous, or adenocarcinoma histology.",
"criterions": [
{
"exact_snippets": "non-squamous",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "non-squamous"
}
]
},
{
"exact_snippets": "adenosquamous",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "adenosquamous"
}
]
},
{
"exact_snippets": "adenocarcinoma",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "adenocarcinoma"
}
]
}
]
},
{
"line": "* Patients with bilateral hydronephrosis that cannot be alleviated by ureteral stents or percutaneous drainage.",
"criterions": [
{
"exact_snippets": "bilateral hydronephrosis",
"criterion": "bilateral hydronephrosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cannot be alleviated by ureteral stents",
"criterion": "alleviation by ureteral stents",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
},
{
"exact_snippets": "cannot be alleviated by ... percutaneous drainage",
"criterion": "alleviation by percutaneous drainage",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients currently receiving any or having received other investigational agents within the last 30 days are ineligible.",
"criterions": [
{
"exact_snippets": "Patients currently receiving any or having received other investigational agents within the last 30 days",
"criterion": "investigational agents",
"requirements": [
{
"requirement_type": "receipt",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with known hypersensitivity to topotecan or cisplatin.",
"criterions": [
{
"exact_snippets": "known hypersensitivity to topotecan",
"criterion": "hypersensitivity to topotecan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known hypersensitivity to ... cisplatin",
"criterion": "hypersensitivity to cisplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with craniospinal metastases.",
"criterions": [
{
"exact_snippets": "craniospinal metastases",
"criterion": "craniospinal metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with uncontrolled current illness including, but not limited to, ongoing or active infection, unstable angina pectoris, cardiac arrhythmia, serious peripheral neuropathy, or psychiatric illness/social situations that would limit or preclude compliance with study requirements are ineligible.",
"criterions": [
{
"exact_snippets": "uncontrolled current illness ... ongoing or active infection",
"criterion": "ongoing or active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... serious peripheral neuropathy",
"criterion": "serious peripheral neuropathy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... psychiatric illness/social situations that would limit or preclude compliance with study requirements",
"criterion": "psychiatric illness/social situations",
"requirements": [
{
"requirement_type": "impact on compliance",
"expected_value": "limit or preclude"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}